Researchers say the study indicates the ability to bring the power of AI and patient-reported outcomes directly into the clinic seamlessly, affordably, and at scale.

Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...

Pfizer has won the week-long bidding war for Metsera with an upwardly revised up-to-$10 billion offer matching that of rival Novo Nordisk—and more than a little help from Washington.

In this eBook, we focus on both considerations for resins, a major operating cost for a vast majority of protein therapeutics, and filtration through a series of articles.

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Engineered human stomach organoids, transplanted into mice, produced insulin-secreting cells, offering a potential new ...

In this GEN webinar, experts from Sampled and Rady Children’s Hospital will discuss the validation and clinical integration ...

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...

Intellia Therapeutics has acknowledged the death of the elderly patient hospitalized last week in its Phase III trial of assessing nexiguran ziclumeran (nex-z) in transthyretin amyloidosis with ...

Maternal type 1 diabetes is associated with specific epigenetic marks in the form of DNA methylation in children.

The company's initial target is immuno-oncology projects but there are plans to expand into autoimmune disease, infectious disease, and more.

The goal of the project is to develop novel approaches that strengthen and reduce the costs of domestic mAb biomanufacturing to protect against and treat infection by filoviruses.